article thumbnail

Biopharma & medical devices cos view advanced infrastructure to propel manufacturing & new drug development

AuroBlog - Aurous Healthcare Clinical Trials blog

It ensures scalability, quality control, and regulatory compliance. By investing in advanced labs, manufacturing facilities, regulatory compliance systems, cybersecurity, and global supply chains, companies can ensure they meet […]

article thumbnail

MR dosage forms revolutionize patient compliance: Girish Nihalani

AuroBlog - Aurous Healthcare Clinical Trials blog

In the ever-evolving pharmaceutical landscape, modified release (MR) dosage forms have emerged as a groundbreaking innovation, providing solutions that significantly improve patient compliance by simplifying complex drug regimens.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

NABL issues clarification on CAB combined ILAC MRA mark for effective compliance

AuroBlog - Aurous Healthcare Clinical Trials blog

The National Accreditation Board for Testing and Calibration Laboratories (NABL) has issued clarification on NABL accredited Conformity Assessment Body (CAB) combined International Laboratory Accreditation Co-operation (ILAC) Mutual Recognition Arrangement (MRA) mark for effective compliance.

article thumbnail

Tamibarotene Fails in Phase III Trial for a Subset of Higher-Risk MDS

XTalks

Syros Pharmaceuticals announced that its cancer drug tamibarotene failed to meet its primary endpoint in the SELECT-MDS-1 Phase III trial. The placebo-controlled SELECT-MDS-1 trial involved 190 patients with complete response rate (CRR) being the study’s primary endpoint. percent and 18.8

Trials 105
article thumbnail

Psychiatry Clinical Trials: Inclusive, Patient-Centric Approaches for Mental Health Research

XTalks

Despite advancements in neuroscience and psychiatry, clinical trials for mental health conditions such as major depressive disorder (MDD), schizophrenia, bipolar disorder and generalized anxiety disorder face unique challenges. One of the main challenges lies in defining and selecting appropriate trial populations.

article thumbnail

Enhancing Access and Retention in Global, Cross-Border Rare Disease Clinical Trials

XTalks

Global rare disease clinical trials face unique challenges due to small patient populations, complex logistics, diverse regulatory environments and cultural differences. Clinical Trial Manager/Sr. These measures enhance recruitment, retention and overall trial success.

article thumbnail

Compliance Challenges in Generic Drug Development: Lessons Learned

Drug Patent Watch

In our latest blog post, we delve into the compliance hurdles that generic drug developers face, and the valuable lessons learned from these experiences. From navigating complex regulatory landscapes to ensuring the integrity of clinical trials, the stakes are high for generic drug manufacturers. Read the full article here: [link]